Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-09-11
1993-04-06
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514879, A61K 3155
Patent
active
052004058
ABSTRACT:
The invention relates to the use of a compound selected from those of formula (I): ##STR1## in which R, R.sub.1, R.sub.2 and n are as defined in the description, for the treatment of cholinergic transmission disorders.
REFERENCES:
CA 80:3401u, Robba et al., 1973.
Corkin, Trends in Neuro Science--TINS, Dec. 1981, pp. 287-290; "Acetyl choline aging and alzheimer's disease--implications for treatment".
Goodman, et al., Goodman & Gillman's "The pharmacological basis of therapeutics", 8th Edition, pp. 131, 145, 146, 147, 1544 (1990).
Adam Gerard
Israel Maurice
Morot-Gaudry Yvette
Renard Pierre
Robba Max
Adir et Compagnie
Hueschen Gordon W.
Jordan Kimberly
Waddell Frederick E.
LandOfFree
Use of N-(1-hexahydroazepinylalkyl) acetamides for the treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of N-(1-hexahydroazepinylalkyl) acetamides for the treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of N-(1-hexahydroazepinylalkyl) acetamides for the treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-536841